MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia

Neurology

Volumn 54, Issue 6, 2000, Pages 1304-1309

  Barber, R ^a   Ballard, C ^a   McKeith, I G ^a   Gholkar, A ^a   O'Brien, J T ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Frontal lobe; MRI; Temporal lobe; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN VENTRICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; LEWY BODY; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENILE DEMENTIA; TEMPORAL LOBE; VOLUMETRY;

EID: 0034724301     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.6.1304     Document Type: Article

References (40)

1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on Dementia with Lewy Bodies International Workshop. Neurology 1996;47:1113-1124.
2. McKeith IG, Fairbairn AF, Perry RH, et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678.
3. Perry EK, McKeith IG, Perry RH. Dementia with Lewy bodies: a common cause of dementia with therapeutic potential. Int J Geriatr Psychopharmacol 1998;1:120-125.
4. Hashimoto M, Kitagaki H, Imamura T, et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998;51:357-362.
5. Harvey GT, Hughes J, McKeith IG, et al. Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study. Psychol Med 1999;29: 181-187.
6. Barber R, Gholkar A, Scheltens P, et al. Medial temporal lobe in dementia with Lewy bodies. Neurology 1999;52:1153-1158.
7. Lehtovirta M, Laakso MP, Soininen H, et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995; 67:65-72.
8. Lehtovirta M, Soininen H, Laakso MP, et al. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. J Neurol Neurosurg Psychiatry 1996;60:644-649.
9. Jack CR Jr, Petersen RC, Xu YC, et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol 1998;43:303-310.
10. Tanaka S, Kawamata J, Shimohana S, et al. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies. Dement Geriatr Cogn Disord 1998;9:90-98.
11. Yasuda M, Mori E, Kitagaki H, et al. Apolipoprotein E e4 allele and whole brain atrophy in late-onset Alzheimer's disease. Am J Psychiatry 1998;155:779-784.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
13. Ballard C, Holmes C, McKeith, I, et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry 1999;156:1039-1045.
14. Roth M, Tym E, Mountjoy C, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
15. Folstein M, Folstein S, McHugh P. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
18. Roman GC, Tatemischi T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIRENS International Workshop. Neurology 1993;43: 250-260.
19. Robb RA. Multidimensional biomedical image display and analysis in the biotechnology computer resource at the Mayo Clinic. Machine Vision and Appliances 1988;1:75-96.
20. Coffey CE, Wilkinson WE, Weiner RD, et al. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993;50:7-16.
21. Duvernoy HM. The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI. Berlin: Springer, 1998.
22. Jack CR Jr, Peterson RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
23. Jack CR Jr, Peterson RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
24. Barber R, Gholkar A, Scheltens P, et al. Apolipoprotein E e4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol 1999;56:961-965.
25. Lippa CF, Johson R, Smith TW. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease. Ann Neurol 1998;43:102-106.
26. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative neuropathological study. Ann Neurol 1994;35:81-88.
27. Lippa CF, Pulaski-Salo D, Dickson DW, Smith TW. Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. J Neurol Sci 1997;147:161-166.
28. Ince P, Irving D, MacArthur F, Perry RH. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 1991;106: 142-152.
29. Dickson DW, Ruan H, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurities specific to DLBD. Neurology 1991;41:1402-1409.
30. O'Brien JT. Is hippocampal atrophy on magnetic resonance imaging a marker for Alzheimer's disease? Int J Geriatr Psychiatry 1995;10:431-435.
31. Huesgen CT, Burger PC, Crain BJ, Johnston GA. In vitro microscopy of the hippocampus in Alzheimer's disease. Neurology 1993;43:145-152.
32. Bobinski M, Wegiel J, Wisniewski HM, et al. Neurofibrillary pathology-correlation with hippocampal atrophy in Alzheimer disease. Neurobiol Aging 1996;17:909-919.
33. Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia. Neurology 1996; 46:668-678.
34. Double KL, Halliday GM, McRitchie DA, Reid WGJ, Hely MA, Morris JGL. Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease. Dement Geriatr Cogn Disord 1996;7:304-313.
35. Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer's disease: differences in cognition, neuropathology, cholinergic dysfunction and synapse density. J Neuropathol Exp Neurol 1997;56:499-508.
36. Gomez-Isla T, Growdon W, McNamara M, et al. Diffuse Lewy body dementia: quantitative neuropathological studies and APOE genotyping. Neurology 1997;48:A140. Abstract.
37. Mann DMA, Snowden JS. THe topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol 1995;89:178-183.
38. Förstl H, Burns A, Luthert P, et al. The Lewy-body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993;162:385-392.
39. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
40. Juottonen K, Lehtovirta M, Helisalmi S, et al. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E ∈4 allele. J Neurol Neurosurg Psychiatry 1998;65:322-327.